In our in vitro model, CO produced after HO-1 overexpression led to increased expression of ECE-1 and ET-1 secretion by CRC cells through the activation of NF-κB and AP-1 in cells harboring a wild-type p53 and in cells with a mutated p53, respectively. The gene discussed is ECE1; the disease is colorectal carcinoma.